6 December 2017, London: Following a phenomenal year of growth and expansion, the Prime Global Group has enhanced its investment in their London location by moving into larger contemporary offices in the heart of the city. Situated on the banks of the Thames and spread over 2 floors, their new base sits halfway between London
Prime Global’s London hub continues to flourish and grow with the introduction to the team of Norbert Brunhuber, PhD, as Director of Client Services for Prime Global’s Core agency. This exemplifies Prime Global’s extraordinary development and expansion throughout 2017.
The Prime Global Group is expanding its senior leadership team with the appointment of Victoria Boswell-Smith, PhD, as Vice President of Client Services, based in their London office. Victoria will be leading Core Medica Ltd and Paragon Medica Ltd whilst current VP, Katherine Kibble, is on maternity leave. Victoria will also be providing support to
Prime Global Does The Great Manchester 10K Run On Sunday 28th May, 22 of our Manchester colleagues will be representing Prime Global in the Great Manchester 10K Run. As The Beatles famously sang, “it was 20 years ago today…” Well, not quite, but 1997 did see the establishment of Prime Global, with just one employees. Now
Market access expert Caroline Ayres helps to de-mystify market access and its importance within global medical communications strategy.
Let’sTalk this World Health Day for #Mental Health. Depression can be prevented and treated, but we need to educate people about how to understand and manage their mental health and wellbeing. Around 50% of people with depression still go untreated and the numbers are rising. Help spread awareness and get the conversation going.
The Paragon team kicked off training this week for The Great Manchester Run, taking place on Sunday 28th May. This year, 18 runners from Prime Global will be taking part from our Knutsford and Macclesfield offices, raising money for charity. First though, time to get training in Tatton Park!
Paragon is supporting ovarian cancer awareness month, increasing exposure of the fifth most common cancer in women, with a particular focus on helping raise awareness of the signs and symptoms of ovarian cancer. Early diagnosis saves lives. Join us on twitter @PrimeGlobalBuzz to help.
An amazing scientific sight at the #atomium, in Brussels. Onyx and ONLY Oncology take a break from meetings to enjoy the sculpture and blue skies #medcomms. Read more >>
Kerry Acheson joins us as Associate Editorial Director for Paragon, based in our brand new Macclesfield office. Kerry brings a wealth of experience to the team having worked in med comms for over 10 years across a range of therapy areas and projects. Kerry has a passion for people, both in training and developing writers,
New Year = New Opportunities. A busy start to the New Year at Prime Global with lots of meetings and presentations to prepare for across a plethora of therapy areas – an exciting year ahead!
Amazing scientific sight…! The teams from ONYX and Only Oncology take a few moments on a recent business trip to admire the Atomium as it gleams against the bright blue Brussels sky!Prime Global 6 February, 2017
Picture + Amazing scientific sight! Thanks to ONYX and Only Oncology for sharing this fantastic pic taken on a recent business trip.
Recently rebranded medical communications agency Prime Global has expanded its operations in the UK, opening an office in Macclesfield, Cheshire.. More in PM Live >>
Read more >>
Read more >>
Read more in PR WEEK…
It’s that time of year… for the annual Christmas party. We had some fantastic events around the world, where we got to celebrate a brilliant year with our colleagues! Here’s to 2017!
Valerie Moss attended the conference, “Publishing, medical writing and authorship: is more transparency needed?” This issue may also be known as ghostwriting. The definition of a ghostwriter is an Individual who inputs substantially, but acknowledged hardly at all for their work. This event focused on discussing issues around authorship and the transparency of medical writing
Wow, what an end to a ‘BRILLIANT’ year! Our fantastic Prime Global people came together here in Knutsford to celebrate. Although, we missed our team mates in the New York and San Francisco offices.
The beginning of the Christmas season is normally a happy season for most. However, the children in our local hospital may not be as lucky as us this year. We want to help give back and bring a smile to their faces by donating these Christmas calendars.
Here’s to our fabulous Christmas jumper winner, Ian! Dressed to impress in his elf outfit and known as #No.1 elf here at Prime Global and the North Pole. Thanks to everyone who took part and helped raise money to our charity Save the children.
Evelina is a fine example of character we strive for at Prime Global. She has helped inspire girls at the local high school and works tremendously hard at everything she does. What a brilliant asset to our team and community.
Medical communications business set to open new offices as Cheshire headcount grows Hot on the heels of its recent brand launch, Prime Global has announced the arrival of a fifth office, opening this November in Macclesfield. The full-service medcomms group is already a worldwide operation, with people in Knutsford, London, New York and San Francisco.
Medical communications business evolves its brand to reflect worldwide operations Leading medcomms and biotech/pharma specialist, The Prime Medical Group, is already a global operation, with offices in New York and San Francisco as well as the UK. With a growing head count and international client base, the business has chosen this moment to create a
The first drug to treat the underlying cause of Duchenne muscular dystrophy, Exondys (eteplirsen) developed by Sarepta Therapeutics, has secured marketing approval from the U.S. Food and Drug Administration. Duchenne muscular dystrophy is a severe type of muscular dystrophy which generally begins around age four in boys and progresses rapidly. www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm521263.htm
Strimvelis, (autologous CD34+ cells transduced to express ADA) the first ex vivo stem cell gene therapy has been approved to treat patients with ADA-SCID (severe combined immunodeficiency due to adenosine deaminase deficiency). Children born with ADA-SCID do not have a heathy, fully functioning immune system and are unable to successfully combat everyday infections. www.gsk.com ›
The team is delivering the first events for a new oncology account, whilst focusing on 2017 planning across all clients. It’s going to be a busy end to the year!
October will be a very busy month indeed, with 279 ongoing live publication projects alone!
We’re delighted to be supporting a new client on a comprehensive communication programme.
Soon we’ll be welcoming new people to our teams in both the US and UK…and we’re actively looking for even more people to join us across all locations.